LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
99928-4 | Leukocytes | PrThr | Pt | Body fld | Ord | Automated | HEM/BC | 1 | Leukocytes [Presence] in Body fluid by Automated | WBC Fld Ql Auto | null | ACTIVE | 2.72 | 2.72 |
9992-9 | R wave amplitude.lead V2 | Elpot | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | R wave amplitude in lead V2 | R wave Amp L-V2 | null | ACTIVE | 1.0i | 2.48 |
99929-2 | Leukocytes | Naric | Pt | Body fld | Qn | Automated count | HEM/BC | 1 | Leukocytes [#/area] in Body fluid by Automated count | WBC #/area Fld Auto | null | ACTIVE | 2.72 | 2.72 |
999-3 | DBG Ag | PrThr | Pt | RBC | Ord | null | BLDBK | 1 | DBG Ag [Presence] on Red Blood Cells | DBG Ag RBC Ql | null | ACTIVE | 1.0 | 2.56 |
99930-0 | Nucleated cells | PrThr | Pt | Body fld | Ord | Automated | HEM/BC | 1 | Nucleated cells [Presence] in Body fluid by Automated | Nuc cell Fld Ql Auto | null | ACTIVE | 2.72 | 2.72 |
99931-8 | Nucleated cells | Naric | Pt | Body fld | Qn | Automated count | HEM/BC | 1 | Nucleated cells [#/area] in Body fluid by Automated count | Nuc cell #/area Fld Auto | null | ACTIVE | 2.72 | 2.72 |
99932-6 | Bacteria | PrThr | Pt | Body fld | Ord | Automated | MICRO | 1 | Bacteria [Presence] in Body fluid by Automated | Bacteria Fld Ql Auto | null | ACTIVE | 2.72 | 2.72 |
99933-4 | Leukocyte clumps | PrThr | Pt | Body fld | Ord | Automated | HEM/BC | 1 | Leukocyte clumps [Presence] in Body fluid by Automated | WBC clumps Fld Ql Auto | null | ACTIVE | 2.72 | 2.72 |
99934-2 | Mainz pain staging system panel | - | Pt | ^Patient | - | Mainz Pain Staging System | PANEL.SURVEY.GNHLTH | 4 | Mainz pain staging system panel [Mainz Pain Staging System] | null | © 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission. | ACTIVE | 2.72 | 2.72 |
99935-9 | Average frequency of primary pain in past 4W | Find | 4W | ^Patient | Ord | null | H&P.HX | 2 | Average frequency of primary pain in past 4 weeks | Avg freq primary pain past 4W | null | ACTIVE | 2.72 | 2.72 |
99936-7 | Average duration of primary pain in past 4W | Find | 4W | ^Patient | Ord | null | H&P.HX | 2 | Average duration of primary pain in past 4 weeks | Avg duration primary pain past 4W | null | ACTIVE | 2.72 | 2.72 |
9993-7 | R wave amplitude.lead V3 | Elpot | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | R wave amplitude in lead V3 | R wave Amp L-V3 | null | ACTIVE | 1.0i | 2.48 |
99937-5 | Fluctuation of primary pain intensity in past 4W | Find | 4W | ^Patient | Ord | null | H&P.HX | 2 | Fluctuation of primary pain intensity in past 4 weeks | Fluct of primary pain intensity past 4W | null | ACTIVE | 2.72 | 2.72 |
99938-3 | Variation of episodic pain intensity in past 4W | Find | 4W | ^Patient | Ord | null | H&P.HX | 2 | Variation of episodic pain intensity in past 4 weeks | Var of episodic pain intensity past 4W | null | ACTIVE | 2.72 | 2.72 |
99939-1 | Pain distribution in past 4W | Find | 4W | ^Patient | Ord | null | H&P.HX | 2 | Pain distribution in past 4 weeks | Pain distribution in past 4W | null | ACTIVE | 2.72 | 2.72 |
99940-9 | Pain medication in the past 4W | Find | 4W | ^Patient | Ord | null | H&P.HX | 2 | Pain medication in the past 4 weeks | Pain medication in the past 4W | null | ACTIVE | 2.72 | 2.72 |
99941-7 | Withdrawn from or reduced dose of pain medication | Find | Pt | ^Patient | Ord | null | H&P.HX | 2 | Withdrawn from or reduced dose of pain medication | Withdrawn or reduced dose of pain med | null | ACTIVE | 2.72 | 2.72 |
99942-5 | Change of physician responsible for pain treatment | Find | Pt | ^Patient | Ord | null | H&P.HX | 2 | Change of physician responsible for pain treatment | Change physician responsible for pain tx | null | ACTIVE | 2.72 | 2.72 |
99943-3 | Frequency of pain related hospitalizations | Find | Pt | ^Patient | Ord | null | H&P.HX | 2 | Frequency of pain related hospitalizations | Freq of pain related hospitalizations | null | ACTIVE | 2.72 | 2.72 |
99944-1 | Number of surgical procedures for pain | Find | Pt | ^Patient | Ord | null | H&P.HX | 2 | Number of surgical procedures for pain | Num surgical procedures for pain | null | ACTIVE | 2.72 | 2.72 |
9994-5 | R wave amplitude.lead V4 | Elpot | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | R wave amplitude in lead V4 | R wave Amp L-V4 | null | ACTIVE | 1.0i | 2.48 |
99945-8 | Number of pain related stays at treatment facility | Find | Pt | ^Patient | Ord | null | H&P.HX | 2 | Number of pain related stays at treatment facility | Num of pain related stays at tx facility | null | ACTIVE | 2.72 | 2.72 |
99946-6 | Total score | Score | Pt | ^Patient | Qn | Mainz Pain Staging System | SURVEY.GNHLTH | 4 | Total score [Mainz Pain Staging System] | null | © 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission. | ACTIVE | 2.72 | 2.72 |
99947-4 | Telecommunication type | Type | Pt | ^Entity | Nom | null | ADMIN | 2 | Entity Telecommunication type | Entity Telecom type | null | ACTIVE | 2.72 | 2.72 |
99948-2 | Telecommunication panel | - | Pt | ^Entity | - | null | PANEL.ADMIN | 2 | Entity Telecommunication panel | Entity Telecom panel | null | ACTIVE | 2.72 | 2.72 |
99949-0 | Telecommunication mode | Type | Pt | ^Entity | Nom | null | ADMIN | 2 | Entity Telecommunication mode | Entity Telecom mode | null | ACTIVE | 2.72 | 2.72 |
99950-8 | State | Loc | Pt | ^Entity | Nom | null | ADMIN | 2 | Entity State | Entity State | null | ACTIVE | 2.72 | 2.72 |
99951-6 | Postal code | Loc | Pt | ^Entity | Nom | null | ADMIN | 2 | Entity Postal code | Entity Postal code | null | ACTIVE | 2.72 | 2.72 |
9995-2 | R wave amplitude.lead V5 | Elpot | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | R wave amplitude in lead V5 | R wave Amp L-V5 | null | ACTIVE | 1.0i | 2.48 |
99952-4 | Address panel | - | Pt | ^Entity | - | null | PANEL.ADMIN | 2 | Entity Address panel | Entity Address panel | null | ACTIVE | 2.72 | 2.72 |
99953-2 | Address | Addr | Pt | ^Entity | Nom | null | ADMIN | 2 | Entity Address | Entity Address | null | ACTIVE | 2.72 | 2.72 |
99954-0 | City | Loc | Pt | ^Entity | Nom | null | ADMIN | 2 | Entity City | Entity City | null | ACTIVE | 2.72 | 2.72 |
99955-7 | Country | Loc | Pt | ^Entity | Nom | null | ADMIN | 2 | Entity Country | Entity Country | null | ACTIVE | 2.72 | 2.72 |
99956-5 | Complete address | Addr | Pt | ^Entity | Nom | null | ADMIN | 2 | Entity Complete address | Entity Complete address | null | ACTIVE | 2.72 | 2.72 |
99957-3 | Address type | Type | Pt | ^Entity | Nom | null | ADMIN | 2 | Entity Address type | Entity Addr type | null | ACTIVE | 2.72 | 2.72 |
99958-1 | Address use | Type | Pt | ^Entity | Nom | null | ADMIN | 2 | Entity Address use | Entity Address use | null | ACTIVE | 2.72 | 2.72 |
99959-9 | Urothelial carcinoma gene expression score | Score | Pt | Urine | Qn | Molgen | MOLPATH | 1 | Urothelial carcinoma gene expression score in Urine by Molecular genetics method | UC gene expression score Ur | null | ACTIVE | 2.72 | 2.72 |
9996-0 | R wave amplitude.lead V6 | Elpot | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | R wave amplitude in lead V6 | R wave Amp L-V6 | null | ACTIVE | 1.0i | 2.48 |
99960-7 | ADAMTS13 gene full mutation analysis | Find | Pt | Bld/Tiss | Doc | Sequencing | MOLPATH | 1 | ADAMTS13 gene full mutation analysis in Blood or Tissue by Sequencing | ADAMTS13 Full Mut Anl Bld/T Seq | null | ACTIVE | 2.72 | 2.72 |
99961-5 | Myeloproliferative neoplasm multigene analysis | Find | Pt | Bld/Tiss | Doc | Molgen | MOLPATH | 1 | Myeloproliferative neoplasm multigene analysis in Blood or Tissue by Molecular genetics method | MPN multigene analysis Bld/T | null | ACTIVE | 2.72 | 2.72 |
99962-3 | JAK2 gene exon 12 full mutation analysis | Find | Pt | Bld/Tiss | Doc | Sequencing | MOLPATH | 1 | JAK2 gene exon 12 full mutation analysis in Blood or Tissue by Sequencing | JAK2 exon 12 Full Mut Anl Bld/T Seq | null | ACTIVE | 2.72 | 2.72 |
99963-1 | JAK2 gene exon 14 full mutation analysis | Find | Pt | Bld/Tiss | Doc | Sequencing | MOLPATH | 1 | JAK2 gene exon 14 full mutation analysis in Blood or Tissue by Sequencing | JAK2 exon 14 Full Mut Anl Bld/T Seq | null | ACTIVE | 2.72 | 2.72 |
99964-9 | MPL gene exon 10 full mutation analysis | Find | Pt | Bld/Tiss | Doc | Sequencing | MOLPATH | 1 | MPL gene exon 10 full mutation analysis in Blood or Tissue by Sequencing | MPL exon 10 Full Mut Anl Bld/T Seq | null | ACTIVE | 2.72 | 2.72 |
99965-6 | ASXL1 gene exon 13 full mutation analysis | Find | Pt | Bld/Tiss | Doc | Sequencing | MOLPATH | 1 | ASXL1 gene exon 13 full mutation analysis in Blood or Tissue by Sequencing | ASXL1 exon 13 Full Mut Anl Bld/T Seq | null | ACTIVE | 2.72 | 2.72 |
99966-4 | KIT gene exon 17 full mutation analysis | Find | Pt | Bld/Tiss | Doc | Sequencing | MOLPATH | 1 | KIT gene exon 17 full mutation analysis in Blood or Tissue by Sequencing | KIT Exon 17 Full Mut Anl Bld/T Seq | null | ACTIVE | 2.72 | 2.72 |
99967-2 | Atypical hemolytic uremic syndrome multigene analysis | Find | Pt | Bld/Tiss | Doc | Molgen | MOLPATH | 1 | Atypical hemolytic uremic syndrome multigene analysis in Blood or Tissue by Molecular genetics method | aHUS multigene analysis Bld/T | null | ACTIVE | 2.72 | 2.72 |
99968-0 | Thrombotic microangiopathy multigene analysis | Find | Pt | Bld/Tiss | Doc | Molgen | MOLPATH | 1 | Thrombotic microangiopathy multigene analysis in Blood or Tissue by Molecular genetics method | TMA multigene analysis Bld/T | null | ACTIVE | 2.72 | 2.72 |
99969-8 | PLG gene full mutation analysis | Find | Pt | Bld/Tiss | Doc | Sequencing | MOLPATH | 1 | PLG gene full mutation analysis in Blood or Tissue by Sequencing | PLG Full Mut Anl Bld/T Seq | null | ACTIVE | 2.72 | 2.72 |
99970-6 | Hereditary thrombocytopenia multigene analysis | Find | Pt | Bld/Tiss | Doc | Molgen | MOLPATH | 1 | Hereditary thrombocytopenia multigene analysis in Blood or Tissue by Molecular genetics method | IT multigene analysis Bld/T | null | ACTIVE | 2.72 | 2.72 |
99971-4 | Hemophagocytic lymphohistiocytosis multigene analysis | Find | Pt | Bld/Tiss | Doc | Molgen | MOLPATH | 1 | Hemophagocytic lymphohistiocytosis multigene analysis in Blood or Tissue by Molecular genetics method | HLH multigene analysis Bld/T | null | ACTIVE | 2.72 | 2.72 |
99972-2 | Hearing loss multigene analysis | Find | Pt | Bld/Tiss | Doc | Molgen | MOLPATH | 1 | Hearing loss multigene analysis in Blood or Tissue by Molecular genetics method | Hearing loss multigene analy Bld/T | null | ACTIVE | 2.72 | 2.72 |
99974-8 | No injury due to a thermal source | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | No risk of injury due to a thermal source | null | null | ACTIVE | 2.72 | 2.72 |
99975-5 | No injury related to a chemical source | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | No injury related to a chemical source | null | null | ACTIVE | 2.72 | 2.72 |
99976-3 | No injury related to a radiation source | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | No injury related to a radiation source | null | null | ACTIVE | 2.72 | 2.72 |
99977-1 | No injury related to transfer &or transport during care | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | No injury related to transfer AndOr transport during care | null | null | ACTIVE | 2.72 | 2.72 |
9997-8 | R wave axis | Angle | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | R wave axis | R wave axis | null | ACTIVE | 1.0i | 2.48 |
99978-9 | No harm related to medications administered | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | No harm related to medications administered | null | null | ACTIVE | 2.72 | 2.72 |
99979-7 | No injury related to unintended retained surgical item | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | No injury related to unintended retained surgical item | null | null | ACTIVE | 2.72 | 2.72 |
99980-5 | Wound is healing or improved from baseline levels | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Wound is healing or improved from baseline levels | null | null | ACTIVE | 2.72 | 2.72 |
99981-3 | Culture and demographics incorporated into plan of care | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Culture and demographics incorporated into plan of care | null | null | ACTIVE | 2.72 | 2.72 |
99982-1 | Care provided is consistent with established plan of care | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Care provided is consistent with established plan of care | null | null | ACTIVE | 2.72 | 2.72 |
99983-9 | Patient's right to privacy is maintained | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Patient's right to privacy is maintained | null | null | ACTIVE | 2.72 | 2.72 |
99984-7 | Patient receives competent and ethical care within legal standards of practice | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Patient receives competent and ethical care within legal standards of practice | null | null | ACTIVE | 2.72 | 2.72 |
99985-4 | Patient receives consistent and comparable care regardless of the setting | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Patient receives consistent and comparable care regardless of the setting | null | null | ACTIVE | 2.72 | 2.72 |
9998-6 | R wave duration.lead AVF | Time | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | R wave duration in lead AVF | R wave dur L-AVF | null | ACTIVE | 1.0i | 2.48 |
99986-2 | Tissue perfusion is maintained at or improved from baseline levels | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Tissue perfusion is maintained at or improved from baseline levels | null | null | ACTIVE | 2.72 | 2.72 |
99987-0 | Gastrointestinal status is maintained at or improved from baseline levels | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Gastrointestinal status is maintained at or improved from baseline levels | null | null | ACTIVE | 2.72 | 2.72 |
99988-8 | Genitourinary status is maintained at or improved from baseline levels | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Genitourinary status is maintained at or improved from baseline levels | null | null | ACTIVE | 2.72 | 2.72 |
99989-6 | Musculoskeletal status is maintained at or improved from baseline levels | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Musculoskeletal status is maintained at or improved from baseline levels | null | null | ACTIVE | 2.72 | 2.72 |
99990-4 | Endocrine status is maintained at or improved from baseline levels | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Endocrine status is maintained at or improved from baseline levels | null | null | ACTIVE | 2.72 | 2.72 |
99991-2 | No signs and symptoms of infection | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | No signs and symptoms of infection | null | null | ACTIVE | 2.72 | 2.72 |
99992-0 | Thermoregulation maintained core body temperature at desired range | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Thermoregulation maintained core body temperature at desired range | null | null | ACTIVE | 2.72 | 2.72 |
99993-8 | No injury related to an incorrect procedure performed | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | No injury related to an incorrect procedure performed | null | null | ACTIVE | 2.72 | 2.72 |
9999-4 | R wave duration.lead AVL | Time | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | R wave duration in lead AVL | R wave dur L-AVL | null | ACTIVE | 1.0i | 2.48 |
99994-6 | Fluid, electrolyte, and acid-base balances are maintained at or improved from baseline levels | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Fluid, electrolyte, and acid-base balances are maintained at or improved from baseline levels | null | null | ACTIVE | 2.72 | 2.72 |
99995-3 | Respiratory status is maintained at or improved from baseline levels | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Respiratory status is maintained at or improved from baseline levels | null | null | ACTIVE | 2.72 | 2.72 |
99996-1 | Cardiovascular status is maintained at or improved from baseline levels | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Cardiovascular status is maintained at or improved from baseline levels | null | null | ACTIVE | 2.72 | 2.72 |
99997-9 | Demonstrates &or reports adequate pain control | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Demonstrates AndOr reports adequate pain control | null | null | ACTIVE | 2.72 | 2.72 |
99998-7 | Neurological status is maintained at or improved from baseline levels | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Neurological status is maintained at or improved from baseline levels | null | null | ACTIVE | 2.72 | 2.72 |